Literature DB >> 3928823

Striatal dopamine distribution in parkinsonian patients during life.

C Nahmias, E S Garnett, G Firnau, A Lang.   

Abstract

Eleven neuropsychologically normal Parkinsonian patients were studied with [18F]6-fluoro-L-dopa and positron tomography. In all of the patients dopaminergic activity was reduced in the putamen on the side opposite to the major motor signs. The reduction was similar in tremulous and rigid patients. In contrast dopaminergic activity was normal in the caudate nuclei. It is argued that the putamen is mainly involved in the regulation of movement while the caudate nuclei assume a role in cognitive processes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3928823     DOI: 10.1016/0022-510x(85)90135-2

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  26 in total

1.  Disturbed functional brain interactions underlying deficient tactile object discrimination in Parkinson's disease.

Authors:  B Weder; N P Azari; U Knorr; R J Seitz; A Keel; M Nienhusmeier; R P Maguire; K L Leenders; H P Ludin
Journal:  Hum Brain Mapp       Date:  2000-11       Impact factor: 5.038

Review 2.  PET and movement disorders.

Authors:  D J Brooks; R S Frackowiak
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

Review 3.  Approaches to the design of biochemical probes for positron emission tomography.

Authors:  J R Barrio
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

4.  Transcranial color-coded sonography helps differentiation between idiopathic Parkinson's disease and vascular parkinsonism.

Authors:  Chung-Fen Tsai; Ruey-Meei Wu; Yu-Weng Huang; Li-Ling Chen; Ping-Keung Yip; Jiann-Shing Jeng
Journal:  J Neurol       Date:  2007-03-31       Impact factor: 4.849

5.  Positron emission tomography studies of neurotransmitter systems.

Authors:  G V Sawle; D J Brooks
Journal:  J Neurol       Date:  1990-12       Impact factor: 4.849

6.  (18)F-DOPA PET with and without MRI fusion, a receiver operator characteristics comparison.

Authors:  Aaron F Struck; Lance T Hall; Joanna E Kusmirek; Catherine L Gallagher; John M Floberg; Christine J Jaskowiak; Scott B Perlman
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-10-15

7.  Movement Disorder in Wilson Disease: Correlation with MRI and Biomarkers of Cell Injury.

Authors:  Jayantee Kalita; Vijay Kumar; Usha K Misra; Sunil Kumar
Journal:  J Mol Neurosci       Date:  2020-07-13       Impact factor: 3.444

8.  Assessment of dopamine metabolism in brain of patients with dementia by means of 18F-fluorodopa and PET.

Authors:  M Itoh; K Meguro; T Fujiwara; J Hatazawa; R Iwata; K Ishiwata; T Takahashi; T Ido; H Sasaki
Journal:  Ann Nucl Med       Date:  1994-11       Impact factor: 2.668

9.  6-18F-L-dopa imaging of the dopamine neostriatal system in normal and clinically normal MPTP-treated rhesus monkeys.

Authors:  D J Doudet; H Miyake; R T Finn; C A McLellan; T G Aigner; R Q Wan; H R Adams; R M Cohen
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

10.  A method of studying pharmacokinetics in man at picomolar drug concentrations.

Authors:  V J Cunningham; V W Pike; D Bailey; C A Freemantle; B C Page; A K Jones; M J Kensett; D Bateman; S K Luthra; T Jones
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.